These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12354137)

  • 1. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin.
    Nørrelund H; Hansen TK; Ørskov H; Hosoda H; Kojima M; Kangawa K; Weeke J; Møller N; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):539-46. PubMed ID: 12354137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy.
    Freda PU; Reyes CM; Conwell IM; Sundeen RE; Wardlaw SL
    J Clin Endocrinol Metab; 2003 May; 88(5):2037-44. PubMed ID: 12727951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels.
    Barkan AL; Dimaraki EV; Jessup SK; Symons KV; Ermolenko M; Jaffe CA
    J Clin Endocrinol Metab; 2003 May; 88(5):2180-4. PubMed ID: 12727973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylated ghrelin secretion is acutely suppressed by oral glucose load or insulin-induced hypoglycemia independently of basal growth hormone secretion in humans.
    Kim SW; Kim KW; Shin CS; Park DJ; Park KS; Cho BY; Lee HK; Kim SY
    Horm Res; 2007; 67(5):211-9. PubMed ID: 17114888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of total and active ghrelin in acromegaly and growth hormone deficiency.
    Jarkovská Z; Rosická M; Marek J; Hána V; Weiss V; Justová V; Lacinová Z; Haluzík M; Krsek M
    Physiol Res; 2006; 55(2):175-181. PubMed ID: 15910166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly.
    Arosio M; Ronchi CL; Gebbia C; Pizzinelli S; Conte D; Cappiello V; Epaminonda P; Cesana BM; Beck-Peccoz P; Peracchi M
    Eur J Endocrinol; 2004 Jan; 150(1):27-32. PubMed ID: 14713276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval.
    Biermasz NR; van den Oever NC; Frölich M; Arias AM; Smit JW; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2003 Mar; 58(3):288-95. PubMed ID: 12608933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin drives GH secretion during fasting in man.
    Muller AF; Lamberts SW; Janssen JA; Hofland LJ; Koetsveld PV; Bidlingmaier M; Strasburger CJ; Ghigo E; Van der Lely AJ
    Eur J Endocrinol; 2002 Feb; 146(2):203-7. PubMed ID: 11834429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of ghrelin secretion by somatostatin analogs in rats.
    Silva AP; Bethmann K; Raulf F; Schmid HA
    Eur J Endocrinol; 2005 Jun; 152(6):887-94. PubMed ID: 15941929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis.
    Vestergaard ET; Hansen TK; Nielsen S; Moller N; Christiansen JS; Jorgensen JO
    Eur J Endocrinol; 2005 Oct; 153(4):545-9. PubMed ID: 16189176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
    Riedel M; Günther T; von zur Mühlen A; Brabant G
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic profile in patients with acromegaly treated with somatostatin analogue.
    Valea A; Carsote M; Ghervan C; Georgescu C
    J Med Life; 2015; 8 Spec Issue(Spec Issue):82-6. PubMed ID: 26361517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly.
    Karavitaki N; Botusan I; Radian S; Coculescu M; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):282-8. PubMed ID: 15730408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome.
    Haqq AM; Stadler DD; Rosenfeld RG; Pratt KL; Weigle DS; Frayo RS; LaFranchi SH; Cummings DE; Purnell JQ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3573-6. PubMed ID: 12915638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients.
    Dall R; Kanaley J; Hansen TK; Møller N; Christiansen JS; Hosoda H; Kangawa K; Jørgensen JO
    Eur J Endocrinol; 2002 Jul; 147(1):65-70. PubMed ID: 12088921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly.
    Hernandez I; Soderlund D; Espinosa-de-los-Monteros AL; Ochoa R; Zarate A; Mercado M
    J Neurosurg; 1999 Apr; 90(4):647-50. PubMed ID: 10193608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.